Elevance Health (ELV) Gross Profit (2009 - 2026)

Elevance Health (ELV) has 18 years of Gross Profit data on file, last reported at $35.8 billion in Q2 2026.

• On a quarterly basis, Gross Profit rose 683.94% year-over-year to $35.8 billion in Q2 2026; TTM through Jun 2026 was $64.8 billion, a 63.24% decrease from a year earlier, with the FY2025 full-year figure at $50.9 billion, down 59.09% from the prior year.
• Gross Profit for Q2 2026 stood at $35.8 billion, up from $5.4 billion in the prior quarter.
• Over the last five years, Gross Profit for ELV reached as high as $88.3 billion in Q4 2024 and fell as low as -$48.2 billion in Q4 2023.
• Historically, Gross Profit has averaged $20.2 billion across 5 years, with a median of $12.6 billion in 2024.
• Across the five-year window, Gross Profit sank 455.04% in 2023 and jumped 683.94% in 2026, its largest moves.
• Year by year, Gross Profit stood at $13.6 billion in 2022, then sank by 455.04% to -$48.2 billion in 2023, then jumped by 282.94% to $88.3 billion in 2024, then sank by 86.77% to $11.7 billion in 2025, then surged by 206.34% to $35.8 billion in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $35.8 billion in Q2 2026, $5.4 billion in Q1 2026, and $11.7 billion in Q4 2025.